Epigenetics of lung cancer

被引:46
作者
Bowman, Rayleen V.
Yang, Ian A.
Semmler, Annalese B. T.
Fong, Kwun M.
机构
[1] Univ Queensland, Brisbane, Qld, Australia
[2] Prince Charles Hosp, Brisbane, Qld 4032, Australia
基金
美国国家卫生研究院;
关键词
non-small cell lung cancer; hypermethylation; hypomethylation HDAC;
D O I
10.1111/j.1440-1843.2006.00859.x
中图分类号
R56 [呼吸系及胸部疾病];
学科分类号
摘要
Epigenetics is the study of heritable changes in gene expression that occur without changes in DNA sequence. It has a role in determining when and where a gene is expressed during development. Perhaps the most well known epigenetic mechanism is DNA methylation whereby cytosines at position 5 in CpG dinucleotides are methylated. Histone modification is another form of epigenetic control, which is quite complex and diverse. Histones and DNA make up the nucleosome which is the structural unit of chromatin which are involved in packaging DNA. Apart from the crucial role epigenetics plays in embryonic development, transcription, chromatin structure, X chromosome inactivation and genomic imprinting, its role in an increasing number of human diseases is more and more recognized. These diseases include cancer, and lung cancer in particular has been increasingly studied for the potential biological role of epigenetic changes with the promise of better and novel diagnostic and therapeutic tools.
引用
收藏
页码:355 / 365
页数:11
相关论文
共 99 条
[1]  
[Anonymous], HUMAN MOL GENETICS
[2]  
Barletta JM, 1997, CANCER RES, V57, P48
[3]   Comparative application of antibody and gene array for expression profiling in human squamous cell lung carcinoma [J].
Bartling, B ;
Hofmann, HS ;
Boettger, T ;
Hansen, G ;
Burdach, S ;
Silber, RE ;
Simm, A .
LUNG CANCER, 2005, 49 (02) :145-154
[4]   Nuclear levels and patterns of histone H3 modification and HP1 proteins after inhibition of histone deacetylases [J].
Bártová, E ;
Pacherník, J ;
Harnicarová, A ;
Kovarík, A ;
Kovaríková, M ;
Hofmanová, J ;
Skalníková, M ;
Kozubek, M ;
Kozubek, S .
JOURNAL OF CELL SCIENCE, 2005, 118 (21) :5035-5046
[5]   Gene-promoter hypermethylation as a biomarker in lung cancer [J].
Belinsky, SA .
NATURE REVIEWS CANCER, 2004, 4 (09) :707-717
[6]   Gene promoter methylation in plasma and sputum increases with lung cancer risk [J].
Belinsky, SA ;
Klinge, DM ;
Dekker, JD ;
Smith, MW ;
Bocklage, TJ ;
Gilliland, FD ;
Crowell, RE ;
Karp, DD ;
Stidley, CA ;
Picchi, MA .
CLINICAL CANCER RESEARCH, 2005, 11 (18) :6505-6511
[7]   Silencing of genes by promoter hypermethylation: key event in rodent and human lung cancer [J].
Belinsky, SA .
CARCINOGENESIS, 2005, 26 (09) :1481-1487
[8]  
Belinsky SA, 2003, CANCER RES, V63, P7089
[9]   Aberrant methylation of p16INK4a is an early event in lung cancer and a potential biomarker for early diagnosis [J].
Belinsky, SA ;
Nikula, KJ ;
Palmisano, WA ;
Michels, R ;
Saccomanno, G ;
Gabrielson, E ;
Baylin, SB ;
Herman, JG .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1998, 95 (20) :11891-11896
[10]   It's about time: Scheduling alters effect of histone deacetylase inhibitors on camptothecin-treated cells [J].
Bevins, RL ;
Zimmer, SG .
CANCER RESEARCH, 2005, 65 (15) :6957-6966